Welcome to LookChem.com Sign In|Join Free
  • or
NSC401904 is a chemical compound that belongs to the class of 3-(Substituted amino)-1H-indazoles. It is a potentially important drug candidate that has shown anti-proliferative activity against a wide range of cancer cell lines in preclinical studies. NSC401904 has also been found to have anti-inflammatory and analgesic properties in animal models, making it a promising candidate for the development of new therapeutic agents for cancer and inflammatory conditions.
Used in Pharmaceutical Industry:
NSC401904 is used as an anti-cancer agent for its anti-proliferative activity against a wide range of cancer cell lines.
NSC401904 is used as an anti-inflammatory agent for its anti-inflammatory properties in animal models.
NSC401904 is used as an analgesic agent for its analgesic properties in animal models.
Further research is needed to fully understand its mechanisms of action and potential clinical applications.

7015-25-0

Post Buying Request

7015-25-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7015-25-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7015-25-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,1 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7015-25:
(6*7)+(5*0)+(4*1)+(3*5)+(2*2)+(1*5)=70
70 % 10 = 0
So 7015-25-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H14O2/c13-12(14)11-8-4-7-10(11)9-5-2-1-3-6-9/h1-3,5-6,10-11H,4,7-8H2,(H,13,14)

7015-25-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-phenylcyclopentane-1-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-Phenyl-cyclopentancarbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7015-25-0 SDS

7015-25-0Relevant academic research and scientific papers

Synthesis of Medium-Sized Carbocycles by Gallium-Catalyzed Tandem Carbonyl-Olefin Metathesis/Transfer Hydrogenation

Djurovic, Alexandre,Vayer, Marie,Li, Zhilong,Guillot, Regis,Baltaze, Jean-Pierre,Gandon, Vincent,Bour, Christophe

supporting information, p. 8132 - 8137 (2019/10/14)

The first examples of a catalytic tandem process involving a ring-closing carbonyl-olefin metathesis and a transfer hydrogenation are described. 1,4-Cyclohexadiene has been used as an H2 surrogate to reduce the cyclic alkenes formed after the m

Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids

-

Page/Page column 22, (2008/06/13)

The present invention relates to a process for the preparation of cis substituted cyclic β-aryl or heteroaryl carboxylic acid derivatives in high diastereo- and enantioselectivity by enantioselective hydrogenation in accordance with the following scheme w

The effect of electrochemically formed aluminum salts on the electrochemical cyclisation of methyl cinnamate

Guellue, Mustafa

, p. 3225 - 3228 (2007/10/03)

Electrochemical cyclisation of methyl cinnamate with dielectrophiles has been improved by the presence of an aluminum salt which was pre-formed in situ by the electrolysis of a carboxylic acid with a sacrificial aluminum anode. High yields of three, five and six-membered cyclic products have been obtained in the reactions of methyl cinnamate with dichloromethane, 1,3- dibromopropane, and 1,4-dibromobutane.

8-substituted xanthines as selective adenosine receptor agents

-

, (2008/06/13)

Xanthine derivatives having general structure (I) including the (R) and (S) enantiomers and racemic mixtures thereof, and the pharmaceutically acceptable salts thereof, wherein R 1 and R 2 are each independently (C 1 -C 4)lower alkyl or (C 2 -C 4)lower al

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7015-25-0